189 related articles for article (PubMed ID: 31265899)
1. Secondary findings from next generation sequencing: Psychological and ethical issues. Family and patient perspectives.
Houdayer F; Putois O; Babonneau ML; Chaumet H; Joly L; Juif C; Michon CC; Staraci S; Cretin E; Delanoue S; Charron P; Chassagne A; Edery P; Gautier E; Lapointe AS; Thauvin-Robinet C; Sanlaville D; Gargiulo M; Faivre L
Eur J Med Genet; 2019 Oct; 62(10):103711. PubMed ID: 31265899
[TBL] [Abstract][Full Text] [Related]
2. Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature.
Delanne J; Nambot S; Chassagne A; Putois O; Pelissier A; Peyron C; Gautier E; Thevenon J; Cretin E; Bruel AL; Goussot V; Ghiringhelli F; Boidot R; Tran Mau-Them F; Philippe C; Vitobello A; Demougeot L; Vernin C; Lapointe AS; Bardou M; Luu M; Binquet C; Lejeune C; Joly L; Juif C; Baurand A; Sawka C; Bertolone G; Duffourd Y; Sanlaville D; Pujol P; Geneviève D; Houdayer F; Thauvin-Robinet C; Faivre L
Eur J Med Genet; 2019 Jun; 62(6):103529. PubMed ID: 30165243
[TBL] [Abstract][Full Text] [Related]
3. Managing the ethical challenges of next-generation sequencing in genomic medicine.
Clarke AJ
Br Med Bull; 2014 Sep; 111(1):17-30. PubMed ID: 25122627
[TBL] [Abstract][Full Text] [Related]
4. Informed consent for exome sequencing research in families with genetic disease: the emerging issue of incidental findings.
Bergner AL; Bollinger J; Raraigh KS; Tichnell C; Murray B; Blout CL; Telegrafi AB; James CA
Am J Med Genet A; 2014 Nov; 164A(11):2745-52. PubMed ID: 25251809
[TBL] [Abstract][Full Text] [Related]
5. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.
Hart MR; Biesecker BB; Blout CL; Christensen KD; Amendola LM; Bergstrom KL; Biswas S; Bowling KM; Brothers KB; Conlin LK; Cooper GM; Dulik MC; East KM; Everett JN; Finnila CR; Ghazani AA; Gilmore MJ; Goddard KAB; Jarvik GP; Johnston JJ; Kauffman TL; Kelley WV; Krier JB; Lewis KL; McGuire AL; McMullen C; Ou J; Plon SE; Rehm HL; Richards CS; Romasko EJ; Miren Sagardia A; Spinner NB; Thompson ML; Turbitt E; Vassy JL; Wilfond BS; Veenstra DL; Berg JS; Green RC; Biesecker LG; Hindorff LA
Genet Med; 2019 May; 21(5):1100-1110. PubMed ID: 30287922
[TBL] [Abstract][Full Text] [Related]
6. Evaluating parents' decisions about next-generation sequencing for their child in the NC NEXUS (North Carolina Newborn Exome Sequencing for Universal Screening) study: a randomized controlled trial protocol.
Milko LV; Rini C; Lewis MA; Butterfield RM; Lin FC; Paquin RS; Powell BC; Roche MI; Souris KJ; Bailey DB; Berg JS; Powell CM
Trials; 2018 Jun; 19(1):344. PubMed ID: 29950170
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
[TBL] [Abstract][Full Text] [Related]
8. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.
Mackley MP; Fletcher B; Parker M; Watkins H; Ormondroyd E
Genet Med; 2017 Mar; 19(3):283-293. PubMed ID: 27584911
[TBL] [Abstract][Full Text] [Related]
9. How do consent forms for diagnostic high-throughput sequencing address unsolicited and secondary findings? A content analysis.
Vears DF; Niemiec E; Howard HC; Borry P
Clin Genet; 2018 Oct; 94(3-4):321-329. PubMed ID: 29888485
[TBL] [Abstract][Full Text] [Related]
10. [Ethical issues in genome-era].
Kosugi S
Nihon Rinsho; 2016 Jun; 74(6):1022-7. PubMed ID: 27311196
[TBL] [Abstract][Full Text] [Related]
11. Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients.
Horiuchi Y; Matsubayashi H; Kiyozumi Y; Nishimura S; Higashigawa S; Kado N; Nagashima T; Mizuguchi M; Ohnami S; Arai M; Urakami K; Kusuhara M; Yamaguchi K
Hum Genet; 2021 Feb; 140(2):321-331. PubMed ID: 32710294
[TBL] [Abstract][Full Text] [Related]
12. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134
[No Abstract] [Full Text] [Related]
13. Factors influencing NCGENES research participants' requests for non-medically actionable secondary findings.
Roche MI; Griesemer I; Khan CM; Moore E; Lin FC; O'Daniel JM; Foreman AKM; Lee K; Powell BC; Berg JS; Evans JP; Henderson GE; Rini C
Genet Med; 2019 May; 21(5):1092-1099. PubMed ID: 30237575
[TBL] [Abstract][Full Text] [Related]
14. Secondary findings from next-generation sequencing: what does actionable in childhood really mean?
Richer J; Laberge AM
Genet Med; 2019 Jan; 21(1):124-132. PubMed ID: 29875419
[TBL] [Abstract][Full Text] [Related]
15. Ethical and legal implications of whole genome and whole exome sequencing in African populations.
Wright GE; Koornhof PG; Adeyemo AA; Tiffin N
BMC Med Ethics; 2013 May; 14():21. PubMed ID: 23714101
[TBL] [Abstract][Full Text] [Related]
16. Genomic sequencing identifies secondary findings in a cohort of parent study participants.
Thompson ML; Finnila CR; Bowling KM; Brothers KB; Neu MB; Amaral MD; Hiatt SM; East KM; Gray DE; Lawlor JMJ; Kelley WV; Lose EJ; Rich CA; Simmons S; Levy SE; Myers RM; Barsh GS; Bebin EM; Cooper GM
Genet Med; 2018 Dec; 20(12):1635-1643. PubMed ID: 29790872
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease.
Hegde M; Santani A; Mao R; Ferreira-Gonzalez A; Weck KE; Voelkerding KV
Arch Pathol Lab Med; 2017 Jun; 141(6):798-805. PubMed ID: 28362156
[TBL] [Abstract][Full Text] [Related]
18. Offering and Returning Secondary Findings in the Context of Exome Sequencing for Hearing Loss: Clinicians' Views and Experiences.
Notini L; Gaff C; Savulescu J; Vears DF
AJOB Empir Bioeth; 2023; 14(2):74-83. PubMed ID: 36595590
[TBL] [Abstract][Full Text] [Related]
19. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.
Ackerman SL; Koenig BA
AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714
[TBL] [Abstract][Full Text] [Related]
20. Adolescents' preferences regarding disclosure of incidental findings in genomic sequencing that are not medically actionable in childhood.
Hufnagel SB; Martin LJ; Cassedy A; Hopkin RJ; Antommaria AH
Am J Med Genet A; 2016 Aug; 170(8):2083-8. PubMed ID: 27149544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
